1. Home
  2. DMRC vs NAUT Comparison

DMRC vs NAUT Comparison

Compare DMRC & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digimarc Corporation

DMRC

Digimarc Corporation

HOLD

Current Price

$6.53

Market Cap

183.5M

Sector

Technology

ML Signal

HOLD

Logo Nautilus Biotechnolgy Inc.

NAUT

Nautilus Biotechnolgy Inc.

HOLD

Current Price

$1.75

Market Cap

218.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMRC
NAUT
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
183.5M
218.6M
IPO Year
2026
2020

Fundamental Metrics

Financial Performance
Metric
DMRC
NAUT
Price
$6.53
$1.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$10.00
$4.00
AVG Volume (30 Days)
195.5K
1.3M
Earning Date
05-12-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.07
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$992.86
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.07
$0.62
52 Week High
$17.47
$4.31

Technical Indicators

Market Signals
Indicator
DMRC
NAUT
Relative Strength Index (RSI) 32.59 34.66
Support Level $6.13 $0.82
Resistance Level $7.10 $1.87
Average True Range (ATR) 0.76 0.17
MACD -0.06 0.00
Stochastic Oscillator 4.12 11.95

Price Performance

Historical Comparison
DMRC
NAUT

About DMRC Digimarc Corporation

Digimarc Corp is a product digitization company delivering business value across industries through identities and cloud-based solutions. Its solutions are Anti-counterfeiting, Internal Compliance, Leak Detection, Piracy Prevention, Product Swap Prevention, Provenance & Authenticity (C2PA), Recycling, and Royalty Monitoring. The group offers services to various industries such as Consumer Packaged Goods, Government, Media, Pharmaceutical, and Retail.

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Share on Social Networks: